Heartflow Q3 2026 Results: Net Loss of $11.5M, Loss Narrows
Heartflow, Inc. reported a total asset base of $355.3 million as of September 30, 2026, with a significant accumulated deficit of $1.14 billion. The company remains focused on its Heartflow FFRCT and Plaque Analysis products while maintaining a liquid position of approximately $167.7 million in cash and short-term investments.
- Key figure
- Net loss $11.5M